Format

Send to

Choose Destination
Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):370-2.

Continuous isoproterenol inhalation therapy in children with severe asthmatic attack.

Author information

1
Department of Pediatrics, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.

Abstract

We studied the 1-type isoproterenol inhalation therapy for patients with severe asthmatic attacks who were admitted at the Department of Allergy of National Children's Hospital from 1981 to 1991. One hour after l-type isoproterenol inhalation therapy, statistically significant effects were noted with regard to the asthmatic status. Moreover, no side effect was found amoung the subjects. From these data, 1-type isoproterenol inhalation therapy is thought to be effective for severe asthmatic attacks.

PMID:
9130582
DOI:
10.1159/000237606
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center